Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Benjamin

Showing results (241-250 of 258) with videos related to

Pageof 26
Sort By:
Cancer|February 15, 2001
Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institutionC A Portera, V Ho, S R Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Phase II study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcomaL L Worth, N Jaffe, R S Benjamin, et al.
Cancer Research|May 1, 1985
Radioimmunoimaging in malignant melanoma with 111In-labeled monoclonal antibody 96.5J L Murray, M G Rosenblum, R E Sobol, et al.
Cancer|September 11, 2001
Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomasJ B Fleming, S B Cantor, D G Varma, et al.
Journal of Neuro-Oncology|January 1, 1984
A phase II trial of 2,5,-diaziridinyl 3,6-bis (carboethoxy amino) 1,4-benzoquinone (AZQ, NSC 182986) in recurrent primary brain tumorsL G Feun, W K Yung, M E Leavens, et al.
Cancer|December 18, 2001
Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcomaJ N Cormier, S R Patel, C E Herzog, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Prognostic factors for survival of patients treated systemically for disseminated melanomaO Eton, S S Legha, T E Moon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomasF Meric, M Milas, K K Hunt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging systemA C Buzaid, M I Ross, C M Balch, et al.
Blood|September 15, 1995
In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I studyS Vadhan-Raj, H E Broxmeyer, M Andreeff, et al.
Pageof 26

Showing results (241-250 of 258) with videos related to

Sort By:
Pageof 26
Cancer|February 15, 2001
Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institutionC A Portera, V Ho, S R Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Phase II study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcomaL L Worth, N Jaffe, R S Benjamin, et al.
Cancer Research|May 1, 1985
Radioimmunoimaging in malignant melanoma with 111In-labeled monoclonal antibody 96.5J L Murray, M G Rosenblum, R E Sobol, et al.
Cancer|September 11, 2001
Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomasJ B Fleming, S B Cantor, D G Varma, et al.
Journal of Neuro-Oncology|January 1, 1984
A phase II trial of 2,5,-diaziridinyl 3,6-bis (carboethoxy amino) 1,4-benzoquinone (AZQ, NSC 182986) in recurrent primary brain tumorsL G Feun, W K Yung, M E Leavens, et al.
Cancer|December 18, 2001
Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcomaJ N Cormier, S R Patel, C E Herzog, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Prognostic factors for survival of patients treated systemically for disseminated melanomaO Eton, S S Legha, T E Moon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomasF Meric, M Milas, K K Hunt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging systemA C Buzaid, M I Ross, C M Balch, et al.
Blood|September 15, 1995
In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I studyS Vadhan-Raj, H E Broxmeyer, M Andreeff, et al.
Pageof 26